Monday, February 09, 2026 | 06:35 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Markets News

Emcure Pharma, Schaeffler shares look bullish; Osho Krishan suggests 'Buy'

Emcure Pharmaceuticals and Schaeffler shares show strong bullish technical setups. Osho Krishan of Angel One recommend 'Buy' with defined stop losses and target prices.

Emcure Pharma, Schaeffler shares look bullish; Osho Krishan suggests 'Buy'
Updated On : 09 Feb 2026 | 6:26 AM IST

Fund Pick: DSP ELSS Tax Saver, a lock-in that paid investors back

ELSS curbed churn, lifting long-term and SIP returns above category averages

Fund Pick: DSP ELSS Tax Saver, a lock-in that paid investors back
Updated On : 08 Feb 2026 | 10:45 PM IST

Tata Motors CV and HDFC AMC seen entering Nifty Next 50, shows data

Tata Motors and HDFC AMC may see strong passive inflows in Nifty Next 50 rejig, while Info Edge and ICICI Lombard face likely exclusion

Tata Motors CV and HDFC AMC seen entering Nifty Next 50, shows data
Updated On : 08 Feb 2026 | 10:38 PM IST

Street signs: Traders eye 26K on Nifty, key test for primary market

Nifty's relief rally revives bullish momentum with traders eyeing 26,000, while commodity volatility boosts MCX volumes and IPO market shows early signs of revival

Street signs: Traders eye 26K on Nifty, key test for primary market
Updated On : 08 Feb 2026 | 10:32 PM IST

Nykaa's revival rests on more than just growth, focus shifts to margins

Sustained margin expansion will shape the durability of its comeback

Nykaa's revival rests on more than just growth, focus shifts to margins
Updated On : 08 Feb 2026 | 10:27 PM IST

Inflation data, Q3 earnings likely to drive stock markets this week

Besides, geopolitical developments and Q3 earnings will also guide market movement during the week

Inflation data, Q3 earnings likely to drive stock markets this week
Updated On : 08 Feb 2026 | 12:04 PM IST

FPIs turn net buyers in Feb, invest ₹8,100 cr in a week on US trade deal

The inflows follow sustained withdrawals in recent months, with FPIs pulling out ₹35,962 crore in January, ₹22,611 crore in December, and ₹3,765 crore in November

FPIs turn net buyers in Feb, invest ₹8,100 cr in a week on US trade deal
Updated On : 08 Feb 2026 | 11:35 AM IST

Mcap of 8 top valued firms surges by ₹4.55 trn, Reliance biggest winner

From the top-10 pack, Reliance Industries, HDFC Bank, Bharti Airtel, ICICI Bank, State Bank of India, Bajaj Finance, Life Insurance Corporation of India (LIC), and Hindustan Unilever were the gainers

Mcap of 8 top valued firms surges by ₹4.55 trn, Reliance biggest winner
Updated On : 08 Feb 2026 | 11:15 AM IST

Worst week in 4 months: Claude casts a long shadow over Indian IT stocks

Indian IT stocks recorded their worst weekly performance in four months, losing over Rs 6.4 trillion in market capitalisation

Worst week in 4 months: Claude casts a long shadow over Indian IT stocks
Updated On : 07 Feb 2026 | 12:15 AM IST

Improving near-term prospects suggest more gains ahead for LIC stock

Q3 FY26 net premium income was Rs 1.3 trillion, up 18 per cent year on year

Improving near-term prospects suggest more gains ahead for LIC stock
Updated On : 06 Feb 2026 | 11:26 PM IST
Rupee sees best week in more than 3 years on back of India-US trade deal
Updated On : 06 Feb 2026 | 11:21 PM IST

Tata Motors PV: Analysts cautiously positive despite Q3 loss, JLR headwinds

Tata Motors Q3FY26 results: Analysts stay cautiously positive as India PV growth improves, JLR outlook stabilises. Targets range ₹310-₹460.

Tata Motors PV: Analysts cautiously positive despite Q3 loss, JLR headwinds
Updated On : 06 Feb 2026 | 10:38 PM IST

Morgan Stanley sees scope for market re-rating in Indian equities

Inexpensive relative valuations, strong policy stimulus and an emerging growth upcycle could support markets, the brokerage says

Morgan Stanley sees scope for market re-rating in Indian equities
Updated On : 06 Feb 2026 | 7:39 PM IST

Technical issues at depositories delays settlement of stock trades

Brokerages face continued trade settlement issues even as NSDL says systems are back to normal, leaving some investors unable to sell stocks

Technical issues at depositories delays settlement of stock trades
Updated On : 06 Feb 2026 | 6:02 PM IST

Anand Rathi flags ₹13 crore fraud linked to off-market share transfers

Anand Rathi Share and Stock Brokers has reported a suspected ₹13-cr fraud involving off-market share transfers from a client's demat account and said it has begun legal action and tightened controls

Anand Rathi flags ₹13 crore fraud linked to off-market share transfers
Updated On : 06 Feb 2026 | 5:44 PM IST

Rupee posts best rise in over three years after India-US trade deal boost

Rupee slips on dollar outflows but logs its strongest weekly gain in over three years after India-US trade deal lifts sentiment

Rupee posts best rise in over three years after India-US trade deal boost
Updated On : 06 Feb 2026 | 4:39 PM IST

Stock Market Close: D-St sees best week in 2-months; Sensex up 266 pts; Nifty ends at 25,694 today

Sensex Today | Stock Market Highlights, Friday: Among the broader markets, the Nifty Midcap 100 and the Smallcap 100 indices were 0.02 per cent and 0.27 per cent down, respectively

Stock Market Close: D-St sees best week in 2-months; Sensex up 266 pts; Nifty ends at 25,694 today
Updated On : 06 Feb 2026 | 3:46 PM IST

Goodyear India, MRF surge up to 16% after strong Q3 result

Volume growth of tyre companies remained healthy, supported by robust momentum in both the OEM and replacement segments, along with continued premiumisation, said Ceat management.

Goodyear India, MRF surge up to 16% after strong Q3 result
Updated On : 06 Feb 2026 | 3:06 PM IST

InCred rejigs India strategy for Feb 26; what's new in high-conviction list

Reviewing the performance of its high-conviction ideas, InCred said Tata Motors Commercial Vehicles, GE Vernova T&D and Thyrocare Technologies have been "big outperformers to Nifty"

InCred rejigs India strategy for Feb 26; what's new in high-conviction list
Updated On : 06 Feb 2026 | 2:46 PM IST

Jubilant Pharmova shares fall over 4% after Q3 net profit declines 17% YoY

Jubilant Pharmova shares: The scrip fell as much as 4.4 per cent to ₹931 per share on the National Stock Exchange (NSE)

Jubilant Pharmova shares fall over 4% after Q3 net profit declines 17% YoY
Updated On : 06 Feb 2026 | 2:36 PM IST